Home » Authors » Omar Ford

Articles by Omar Ford

Silver: Secret weapon against MRSA, other bacterial infections

Nov. 19, 2007

Pfizer to pay Nektar $135 million fee for abandoning Exubera

Nov. 14, 2007

For tonsil/adenoid removal, PITA procedures offer faster recovery

Nov. 13, 2007

BioTime, Argonne form partnership for therapeutic hypothermia study

Nov. 7, 2007

Market/technology updates: Study data favors bypass surgery over PCI/stenting

Nov. 1, 2007

MichBio effort tries 'virtual' for boost to its life sciences

Nov. 1, 2007

New Ventures: Device/drug combo to be ExThera focus

Nov. 1, 2007

Study shows bypass surgery more effective than stenting

Oct. 30, 2007

Thompson: change or 'collapse' the options facing healthcare

Oct. 29, 2007

Kickbacks are eroding trust, increasingly ‘losing juries’

Oct. 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...